Jean-Pierre Sommadossi
CIK 1296995 · President, CEO, and Chairman · last filed 2026-02-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$28.92M
Companies
3
Total Filings
21
Lifetime Open-Market Net
-$457.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVIR | President, CEO, and Chairman | 6,439,948 | $4.49 | $28.92M | -$457.0K | 9 | 2026-02-03 |
| Kezar Life Sciences, Inc. (KZR) Delisted | Director | 143,182 | $7.29 | $1.04M | $0 | 4 | 2021-06-30 |
| IDENIX PHARMACEUTICALS INC (IDIX) Delisted | President, CEO, Chairman | 2,219,754 | — | — | $0 | 7 | 2010-02-11 |
Recent Filings · Page 3 of 3
21 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-03-30 | IDENIX PHARMACEUTICALS INC (IDIX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–21 of 21
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.